single

Alembic Pharmaceuticals announced that the Company has receivedapproval from the US Food & Drug Administration (USFDA) for its Abbreviated NewDrug Application (ANDA) for Dorzolamide Hydrochloride Ophthalmic Solution USP,2%. The approved ANDA is therapeutically equivalent to the reference listed drugproduct (RLD) Trusopt Ophthalmic Solution, 2%, of Merck Sharp & Dohme Corp.Dorzolamide Hydrochloride Ophthalmic Solution is a carbonic anhydrase inhibitorindicated in the treatment of elevated intraocular pressure in patients with ocularhypertension or open-angle glaucoma.

Dorzolamide Hydrochloride Ophthalmic Solution USP, 2% has an estimated marketsize of US$ 35 million for twelve months ending December 2018 according to IQVIA

TAGS

0 thoughts on “Alembic Pharmaceuticals receives USFDA ANDA approval for Dorzolamide Hydrochloride Ophthalmic Solution”

Post Comment



  Share Tips

Intraday trading is an art of earning money from stock market and it requires a lot of patience and time to allocate in the daily schedule. But to see money from market is not an easy thing which it always do not gives opportunity with high profits. Many people do not have time to do intraday trading in their daily jobs in office or business. But here we make it very simple and easy.



Daily News

VIEW ALL
View My Stats